Advertisement
Dietary fat

Fat, Protein, Glycemic Index All Modify Postprandial Glycemia

0
High-fat/protein meals need more insulin than lower-fat/protein meals with same carbohydrate content
A genetically engineered form of the herpes virus is showing promise in slowing the progression of melanoma

HSV-Derived Immunotherapy Promising in Advanced Melanoma

0
Study shows it helped a minority of patients, and experts say this approach has promise
Newer forms of combined oral contraceptives pills -- brands such as Yaz

Higher Risk of VTE With Newer Forms of Oral Contraceptives

0
Includes brands such as Yaz, Yasmin, Desogen; risk to any one user remains very low
While patients with three or four heart risk factors should still be given a β-blocker before surgery

Pre-Op β-Blockers May Work Against Heart-Healthy Patients

0
But those with three or four heart risk factors may benefit from getting β-blockers
Potential mechanisms for the antiatherosclerotic activity of methotrexate and adalimumab in rheumatoid arthritis have been identified

Antiatherosclerotic Activity ID’d for MTX, Adalimumab in RA

0
Activity may be mediated by effects on lipoprotein functions, macrophage metabolism
Caution should be exercised with use of electronic health record documentation short cuts

Caution Urged When Using EHR Shortcut Features

0
Information should be checked and updated to avoid cloning and up-coding
For patients with type 2 diabetes

Gender-Based Differences in Glycemic Control in T2DM

0
Women have smaller improvement in HbA1c and more hypoglycemia and nocturnal hypoglycemia
The number of infants born to American mothers who are chronic opioid users is rising

Costs of Neonatal Abstinence Syndrome on the Rise

0
Researchers encourage physicians to be proactive in screening for drug use
Consuming more omega-3 fatty acids may benefit patients at risk for Alzheimer's disease

Increasing Omega-3 Intake May Boost Cognitive Flexibility

0
Findings among those aged 65 to 75, who had gene variant APOE ε4
Beloranib seems efficacious and safe for weight loss in obese patients

Beloranib Safe, Efficacious for Weight Loss in Obesity

0
Tolerable at doses of 0.6 and 1.2 mg; more adverse events with dose of 2.4 mg